Liquid Biopsy IVD Market, Global Outlook and Forecast 2023-2028

Report ID: 1211234 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report contains market size and forecasts of Liquid Biopsy IVD in Global, including the following market information:
Global Liquid Biopsy IVD Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Liquid Biopsy IVD market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Circulating Tumor Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Liquid Biopsy IVD include Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, OME Care, NeoGenomics Laboraories and Sysmex Inostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liquid Biopsy IVD companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liquid Biopsy IVD Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Liquid Biopsy IVD Market Segment Percentages, by Type, 2021 (%)
Circulating Tumor Cells
Circulating Tumor DNA
Extracellular Vesicles
Others
Global Liquid Biopsy IVD Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Liquid Biopsy IVD Market Segment Percentages, by Application, 2021 (%)
Blood Sample Based
Urine Sample Based
Other Bio Fluids Based
Global Liquid Biopsy IVD Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Liquid Biopsy IVD Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liquid Biopsy IVD revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Liquid Biopsy IVD revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
OME Care
NeoGenomics Laboraories
Sysmex Inostics
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

Frequently Asked Questions
Liquid Biopsy IVD Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liquid Biopsy IVD Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liquid Biopsy IVD Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports